πŸ‡ΊπŸ‡Έ FDA
Patent

US 8048432

Polysaccharide-protein conjugate vaccines

granted A61KA61K2039/6037A61K2039/6087

Quick answer

US patent 8048432 (Polysaccharide-protein conjugate vaccines) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/6037, A61K2039/6087, A61K2039/627, A61K39/00